Distribution and concentration of cyclosporin in human blood.
Open Access
- 1 October 1984
- journal article
- research article
- Published by BMJ in Journal of Clinical Pathology
- Vol. 37 (10) , 1167-1171
- https://doi.org/10.1136/jcp.37.10.1167
Abstract
In patients receiving cyclosporin to minimise graft versus host disease after allogeneic bone marrow transplantation, whole blood cyclosporin concentration was roughly twice the serum concentration when blood was separated at 37 degrees C. In turn, blood separation at 37 degrees C resulted in a doubling of serum cyclosporin concentration compared with separation at room temperature. In vitro studies showed that the latter phenomenon was due to a temperature dependent partitioning of cyclosporin between plasma and red cells, such that increased cyclosporin was taken up from the serum into red cells at room temperature. Increasing delay in separation of patient blood (at either temperature) resulted in a gradually increasing cyclosporin serum concentration. Further in vitro studies showed that a distribution equilibrium between blood components was reached within 30 min incubation. Red cell uptake of cyclosporin was saturable at an incubation concentration of greater than 4 microgram/ml, while plasma and mononuclear cells showed a linear uptake to 7 micrograms/ml. The cellular cyclosporin content of a mononuclear cell was roughly 1000 times greater than that of an erythrocyte. For clinical monitoring we recommend the measurement of cyclosporin concentration either in whole blood or in serum separated at 37 degrees C without delay after venepuncture.This publication has 18 references indexed in Scilit:
- CYCLOSPORINE-ASSOCIATED CENTRAL NERVOUS SYSTEM TOXICITY AFTER ALLOGENEIC BONE MARROW TRANSPLANTATIONTransplantation, 1984
- Oral administration of cyclosporin A for recipients of allogeneic marrow transplants: implications of clinical gut dysfunctionBritish Journal of Haematology, 1984
- In vitro stability of cyclosporin A.Journal of Clinical Pathology, 1983
- Nephrotoxicity in bone marrow transplant recipients treated with cyclpsporin ABritish Journal of Haematology, 1983
- Stability of cyclosporin A in human serum.Journal of Clinical Pathology, 1983
- Cyclosporin A as prophylaxis against graft-versus-host disease in 36 patients.BMJ, 1982
- USE OF CYCLOSPORIN A IN ALLOGENEIC BONE MARROW TRANSPLANTATION FOR SEVERE APLASTIC ANEMIATransplantation, 1982
- Heart-Lung TransplantationNew England Journal of Medicine, 1982
- Nephrotoxicity of Cyclosporin a after Allogeneic Marrow TransplantationNew England Journal of Medicine, 1981
- Cyclosporin A mediates immunosuppression of primary cytotoxic T cell responses by impairing the release of interleukin 1 and interleukin 2European Journal of Immunology, 1981